b6 with tirzepatide B6: complete guide to the pyridoxine compound formulation ✨ Did you know? ✨

Novo Nordisk announced FDA acceptance of their New Drug Application (NDA) for a 25 mg oral version of Wegovy for two new indications: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of MACE in adults with overweight or obesity and established CVD

H.WebsterL

Ye F, Mathur S, Liu M, et al

Body mass index and body composition will be completed to set goals for losing weight safely

Seven to nine hours of quality sleep per night supports the metabolic environment that allows tirzepatide to work optimally

FDA warning letters issued